I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
LoRusso, P.
1117
results:
Search for persons
X
Format
Online (1117)
Mediatypes
Articles (Online) (418)
Bookchapter (Online) (11)
OpenAccess-fulltext (688)
Languages
english (962)
italian (7)
Sorted by: Relevance
Sorted by: Year
?
1
56O A phase Ia/Ib study of the MDM2-p53 antagonist brigimad..:
Schöffski, P.
;
Lorusso, P.
;
Yamamoto, N.
...
ESMO Open. 9 (2024) - p. 102446 , 2024
Link:
https://doi.org/10.1016/..
?
2
Qualification Activities for the DTT Divertor:
Giorgetti, F.
;
Roccella, S.
;
Crea, F.
...
IEEE Transactions on Plasma Science. , 2024
Link:
https://doi.org/10.1109/..
?
3
184MO First-in-human phase I/IIa study of the first-in-clas..:
Yap, T.A.
;
Sharma, M.R.
;
Hamilton, E.P.
...
ESMO Open. 9 (2024) - p. 103206 , 2024
Link:
https://doi.org/10.1016/..
?
4
61MO Phase Ia/Ib study of the MDM2-p53 antagonist brigimadl..:
Reichardt, P.
;
Schöffski, P.
;
Lorusso, P.
...
ESMO Open. 9 (2024) - p. 102451 , 2024
Link:
https://doi.org/10.1016/..
?
5
Brazing alloys characterization for EU-DEMO Divertor Target:
Lorusso, P.
;
Martelli, E.
;
Cacciotti, E.
...
Fusion Engineering and Design. 205 (2024) - p. 114514 , 2024
Link:
https://doi.org/10.1016/..
?
6
Lead Fast Reactor Thermal-Hydraulic Testing Facilities in S..:
Liao, J.
;
Stansbury, C. A.
;
Durse, M. E.
...
Nuclear Technology. , 2024
Link:
https://doi.org/10.1080/..
?
7
Armor Thickness Assessment for the Divertor Tokamak Test Fa..:
Roccella, Selanna
;
Giorgetti, F.
;
Luca, R. De
...
IEEE Transactions on Plasma Science. , 2024
Link:
https://doi.org/10.1109/..
?
8
126P Evaluation of myeloid targeting agents, PY159 and PY31..:
Yeku, O.O.
;
Barve, M.
;
Tan, W.W.
...
Immuno-Oncology and Technology. 20 (2023) - p. 100598 , 2023
Link:
https://doi.org/10.1016/..
?
9
161TiP A phase I/II, open-label study of an anti-ILT2 (LILR..:
Perets, R.
;
Stemmer, S.M.
;
Geva, R.
...
Immuno-Oncology and Technology. 20 (2023) - p. 100672 , 2023
Link:
https://doi.org/10.1016/..
?
10
Thermo-fluid dynamic analysis of HLM pool. Circe experiment:
Martelli, D.
;
Marinari, R.
;
Di Piazza, I.
..
Nuclear Engineering and Design. 409 (2023) - p. 112347 , 2023
Link:
https://doi.org/10.1016/..
?
11
Subchannel modelling capabilities of RELAP5-3D© for wire-sp..:
Ciurluini, C.
;
Narcisi, V.
;
Giannetti, F.
...
Nuclear Engineering and Design. 409 (2023) - p. 112353 , 2023
Link:
https://doi.org/10.1016/..
?
12
42O A phase Ia/b, dose-escalation and expansion study evalu..:
Schoeffski, P.
;
Yamamoto, N.
;
Bauer, T.
...
ESMO Open. 8 (2023) 1 - p. 101079 , 2023
Link:
https://doi.org/10.1016/..
?
13
Improvement of ALFRED thermal hydraulics through experiment..:
Caramello, M.
;
Frignani, M.
;
Grasso, G.
...
Nuclear Engineering and Design. 409 (2023) - p. 112365 , 2023
Link:
https://doi.org/10.1016/..
?
14
State-of-the-art review of the T/H system codes RELAP5 for ..:
Lorusso, P.
;
Polidori, M.
;
Del Nevo, A.
...
Nuclear Engineering and Design. 414 (2023) - p. 112627 , 2023
Link:
https://doi.org/10.1016/..
?
15
ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS ..:
Amengual, J. E.
;
Shyr, Y.
;
Durecki, D.
...
Hematological Oncology. 41 (2023) S2 - p. 833-834 , 2023
Link:
https://doi.org/10.1002/..
1-15